Germline BRCA1/2 Mutations
1 clinical trials · Condition
◉ Watch Germline BRCA1/2 Mutations
| Record | Firm | Date |
|---|---|---|
| To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients. (NCT03286842) | AstraZeneca | 2018-01-17 |
Track Germline BRCA1/2 Mutations automatically
Every clearance here is in the API, with alerts when new ones post.